BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Capiau A, De Backer T, Grymonprez M, Lahousse L, Van Tongelen I, Mehuys E, Boussery K. Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and the EHRA Practical Guide. Int J Cardiol 2021;328:97-103. [PMID: 33279589 DOI: 10.1016/j.ijcard.2020.11.062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Capiau A, Mehuys E, Dhondt E, De Backer T, Boussery K. Physicians' and pharmacists' views and experiences regarding use of direct oral anticoagulants in clinical practice. Br J Clin Pharmacol 2021. [PMID: 34625983 DOI: 10.1111/bcp.15106] [Reference Citation Analysis]
2 Stöllberger C, Finsterer J. Update on drug interactions with non-vitamin-K-antagonist oral anticoagulants for stroke prevention in elderly patients. Expert Rev Clin Pharmacol 2021;14:569-81. [PMID: 33757376 DOI: 10.1080/17512433.2021.1908124] [Reference Citation Analysis]
3 Arantes FBB, Furtado RHM. The great discovery of DOACs and why physicians insist on misusing it: A paradox of the 21 century. Int J Cardiol 2022:S0167-5273(22)00809-9. [PMID: 35659556 DOI: 10.1016/j.ijcard.2022.05.061] [Reference Citation Analysis]